IL149592A0 - Synthesis of 2'-deoxy-l-nucleosides - Google Patents

Synthesis of 2'-deoxy-l-nucleosides

Info

Publication number
IL149592A0
IL149592A0 IL14959200A IL14959200A IL149592A0 IL 149592 A0 IL149592 A0 IL 149592A0 IL 14959200 A IL14959200 A IL 14959200A IL 14959200 A IL14959200 A IL 14959200A IL 149592 A0 IL149592 A0 IL 149592A0
Authority
IL
Israel
Prior art keywords
nucleosides
deoxy
synthesis
Prior art date
Application number
IL14959200A
Other languages
English (en)
Original Assignee
Pharmasset Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmasset Ltd filed Critical Pharmasset Ltd
Publication of IL149592A0 publication Critical patent/IL149592A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14959200A 1999-11-12 2000-11-13 Synthesis of 2'-deoxy-l-nucleosides IL149592A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16508799P 1999-11-12 1999-11-12
PCT/US2000/031107 WO2001034618A2 (en) 1999-11-12 2000-11-13 Synthesis of 2'-deoxy-l-nucleosides

Publications (1)

Publication Number Publication Date
IL149592A0 true IL149592A0 (en) 2002-11-10

Family

ID=22597367

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14959200A IL149592A0 (en) 1999-11-12 2000-11-13 Synthesis of 2'-deoxy-l-nucleosides
IL149592A IL149592A (en) 1999-11-12 2002-05-12 Synthesis of 2 '- deoxy - L - nucleosides

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL149592A IL149592A (en) 1999-11-12 2002-05-12 Synthesis of 2 '- deoxy - L - nucleosides

Country Status (12)

Country Link
US (1) US20050090660A1 (xx)
EP (1) EP1232166A2 (xx)
JP (1) JP2003513984A (xx)
KR (1) KR100789162B1 (xx)
CN (4) CN1919860A (xx)
AU (3) AU784374C (xx)
BR (1) BR0015530A (xx)
CA (1) CA2391279A1 (xx)
IL (2) IL149592A0 (xx)
MX (1) MXPA02004779A (xx)
TR (3) TR200601784T2 (xx)
WO (1) WO2001034618A2 (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6822089B1 (en) 2000-03-29 2004-11-23 Isis Pharmaceuticals, Inc. Preparation of deoxynucleosides
PT1411954E (pt) * 2000-10-18 2011-03-16 Pharmasset Inc Nucleosídeos modificados para o tratamento de infecções virais e proliferação celular anormal
DE10216426A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Verfahren zur Herstellung von beta-L-2'Deoxy-Thymidin
TWI244393B (en) * 2002-08-06 2005-12-01 Idenix Pharmaceuticals Inc Crystalline and amorphous forms of beta-L-2'-deoxythymidine
BRPI0419345B8 (pt) * 2003-05-30 2021-05-25 Gilead Pharmasset Llc uso do (2’r)-2’-desoxi-2’-flúor-2’-c-metil nucleosídeo e de uma composição farmacêutica que o compreende
WO2005026186A1 (de) * 2003-09-12 2005-03-24 Max-Delbrück-Centrum für Molekulare Medizin Β-l-nucleoside und ihre verwendung als pharmazeutische mittel zur behandlung viraler erkrankungen
CN101023094B (zh) * 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
RU2433124C2 (ru) * 2004-09-14 2011-11-10 Фармассет, Инк. Способ получения 2'-фтор-2'-алкилзамещенных или других замещенных рибофуранозилпиримидинов и пуринов и их производных
US7759342B2 (en) 2005-01-13 2010-07-20 Signal Pharmaceuticals, Llc Methods of treatment and prevention using haloaryl substituted aminopurines
US7521446B2 (en) 2005-01-13 2009-04-21 Signal Pharmaceuticals, Llc Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
US7723340B2 (en) 2005-01-13 2010-05-25 Signal Pharmaceuticals, Llc Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
JP4995811B2 (ja) * 2005-04-29 2012-08-08 クック・バイオテック・インコーポレーテッド 瘻治療用容積式移植片並びに関連の方法及びシステム
US7964580B2 (en) * 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
US8979882B2 (en) * 2008-07-21 2015-03-17 Arstasis, Inc. Devices, methods, and kits for forming tracts in tissue
NZ593021A (en) * 2008-11-17 2013-04-26 Anadys Pharmaceuticals Inc Method of preparing deoxyribofuranose compounds
EP2376515A1 (en) 2008-12-23 2011-10-19 Pharmasset, Inc. Synthesis of purine nucleosides
AR074897A1 (es) 2008-12-23 2011-02-23 Pharmasset Inc Fosforamidatos de nucleosidos
SG172361A1 (en) 2008-12-23 2011-07-28 Pharmasset Inc Nucleoside analogs
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
CN101555266B (zh) * 2009-05-25 2011-11-30 上海医药工业研究院 一种替比夫定的制备方法
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
PT3290428T (pt) 2010-03-31 2021-12-27 Gilead Pharmasset Llc Comprimido compreendendo 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1-(2h)-il)¿4¿fluoro¿3¿hidroxi¿4¿metiltetrahidrofuran¿2¿il)metoxi) (fenoxi)fosforil)amino)propanoato de (s)- isopropil cristalino
KR101198302B1 (ko) 2010-11-02 2012-11-07 서울대학교산학협력단 Ｃｄｋ를 저해하는 피롤로피리미디논 카복사미드 유도체 또는 이의 약학적으로 허용가능한 염, 이를 유효성분으로 함유하는 간세포암의 예방 또는 치료용 약학적 조성물
PT3042910T (pt) 2010-11-30 2019-04-16 Gilead Pharmasset Llc 2'-espiro-nucleósidos para utilização na terapia da hepatite c
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
EP2888008B1 (en) * 2012-08-22 2018-12-26 Merck Sharp & Dohme Corp. Novel azabenzimidazole tetrahydrofuran derivatives
AU2014311827B2 (en) 2013-08-27 2017-09-14 Gilead Sciences, Inc. Combination formulation of two antiviral compounds
AU2019274590A1 (en) * 2018-05-25 2021-01-14 Primmune Therapeutics, Inc. TLR7 agonists
CN109020974B (zh) * 2018-11-02 2021-01-05 哈尔滨商业大学 5′-噻吩甲酰酯-3′-脱氧腺苷的合成方法及其应用
CN109369758B (zh) * 2018-11-02 2021-04-13 哈尔滨商业大学 5′-(6-氯烟酰酯)-3′-脱氧腺苷的合成方法及其应用
CN109111445B (zh) * 2018-11-02 2020-12-18 哈尔滨商业大学 5’-呋喃甲酰酯-3’-脱氧腺苷的合成方法及应用
EP4065155A4 (en) 2019-11-26 2023-11-29 Primmune Therapeutics, Inc. TLR7 AGONISTS

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5041449A (en) * 1988-04-11 1991-08-20 Iaf Biochem International, Inc. 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5200514A (en) * 1990-01-19 1993-04-06 University Of Georgia Research Foundation, Inc. Synthesis of 2'-deoxypyrimidine nucleosides
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
IT1246983B (it) * 1990-11-13 1994-12-12 Consiglio Nazionale Ricerche L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
FR2709754B1 (fr) * 1993-09-10 1995-12-01 Centre Nat Rech Scient Composés 2' ou 3'-déoxy- et 2', 3'-didéoxy-beta-L-pentofuranonucléosides, procédé de préparation et application thérapeutique, notamment anti-virale.
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
US6025335A (en) * 1995-09-21 2000-02-15 Lipitek International, Inc. L-Nucleoside Dimer Compounds and therapeutic uses
KR100634342B1 (ko) * 1998-08-10 2006-10-16 이데닉스(케이만)리미티드 B형 간염의 치료용 β-L-2'-데옥시-뉴클레오시드
US6444652B1 (en) * 1998-08-10 2002-09-03 Novirio Pharmaceuticals Limited β-L-2'-deoxy-nucleosides for the treatment of hepatitis B
US6407077B1 (en) * 1998-11-05 2002-06-18 Emory University β-L nucleosides for the treatment of HIV infection

Also Published As

Publication number Publication date
AU2005204267A1 (en) 2005-09-22
AU2005204266B2 (en) 2008-11-06
TR200601783T2 (tr) 2007-01-22
WO2001034618A3 (en) 2002-01-03
CN1919860A (zh) 2007-02-28
AU2005204267B2 (en) 2008-10-23
CA2391279A1 (en) 2001-05-17
EP1232166A2 (en) 2002-08-21
CN1919858A (zh) 2007-02-28
JP2003513984A (ja) 2003-04-15
AU784374B2 (en) 2006-03-23
CN1423654A (zh) 2003-06-11
CN1919859A (zh) 2007-02-28
AU2005204266A1 (en) 2005-09-22
BR0015530A (pt) 2003-02-18
US20050090660A1 (en) 2005-04-28
TR200601782T2 (tr) 2006-09-21
MXPA02004779A (es) 2004-07-01
AU784374C (en) 2007-06-28
TR200601784T2 (tr) 2007-01-22
KR20030025220A (ko) 2003-03-28
KR100789162B1 (ko) 2007-12-28
AU1485801A (en) 2001-06-06
IL149592A (en) 2008-11-26
WO2001034618A2 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
IL149592A0 (en) Synthesis of 2'-deoxy-l-nucleosides
IL178864A0 (en) 3'-prodrugs of 2'-deoxy-??-l-nucleosides
EP1054836A4 (en) SYNTHESIS OF ZSM-48
PL326604A1 (en) Derivatives of 5"-dezoxy-cytidin
IL126272A0 (en) Synthesis of indolylmaleimides
EG22530A (en) Preparation of substituted piperidin-4-ones
IL128376A0 (en) Synthesis of bisindolylmalimides
EP1218407A4 (en) USES OF KAPPA-CONOTOXIN PVIIA
GB9909756D0 (en) Synthesis of polycarbonates
IL144572A0 (en) Regulation of anaesthesia
HUP0201610A2 (en) Derivatives of 4'-demycarosyl-8a-aza-8a-homotylosin
DE69908936D1 (en) 2''-deoxyhygromycinderivate
PL350963A1 (en) Use of arylalkanoylpyridazines
GB9727123D0 (en) Synthesis of diamines
EP0923519A4 (en) PRODUCTION OF HALOALKYNOLS
IL137918A0 (en) Solid support synthesis of 2-oxopiperazines
GB9800464D0 (en) Efficient synthesis of cycloproplacetylene
GB2393957B (en) Synthesis of hexaazaisowurtzitane derivatives
GB9807369D0 (en) First efficient synthesis of x-mapi
GB9712871D0 (en) Synthesis of ketones
GB9917115D0 (en) ›-lactone synthesis
AP2007003992A0 (en) 3'-Prodrugs of 2'-deoxy-beta-l-nucleosides
GB9810059D0 (en) Synthesis of substituted pyran-2-ones
GB9709531D0 (en) Synthesis of substituted pyran-2-ones
TW405342U (en) Improvement of buckle structure

Legal Events

Date Code Title Description
FF Patent granted